Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes.
暂无分享，去创建一个
H. Sakamoto | Y. Yamaguchi | E. Sakai | T. Tsukuba | K. Okamoto | Y. Fukuma | K. Nishishita | Reiko Fumimoto | Megumi Shimada-Sugawara | Yutaka Fukuma